You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 17, 2025

Details for Patent: 11,826,335


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,826,335 protect, and when does it expire?

Patent 11,826,335 protects LUMRYZ and is included in one NDA.

This patent has thirty patent family members in ten countries.

Summary for Patent: 11,826,335
Title:Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
Abstract:Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
Inventor(s):Jordan Dubow, Hervé Guillard, Claire Mégret, Jean-François DUBUISSON
Assignee:Flamel Ireland Ltd
Application Number:US18/096,508
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,826,335: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance and implications. This article will provide a detailed analysis of United States Patent 11,826,335, focusing on its claims, the technological context, and the relevant legal and procedural aspects.

Patent Overview

To begin, it is essential to identify the key elements of the patent:

  • Patent Number: 11,826,335
  • Title: [Insert title from the patent document]
  • Inventors: [Insert inventors' names from the patent document]
  • Assignee: [Insert assignee's name from the patent document]
  • Filing Date: [Insert filing date from the patent document]
  • Grant Date: [Insert grant date from the patent document]

Claims Analysis

The claims section of a patent is critical as it defines the scope of the invention and what is protected by the patent.

Independent Claims

Independent claims stand alone and do not rely on other claims. They typically define the broadest scope of the invention.

  • Claim 1: [Insert the text of Claim 1 from the patent document]
    • This claim sets the foundation for the invention, outlining the core elements and their relationships.

Dependent Claims

Dependent claims build upon the independent claims, often adding specific details or limitations.

  • Claim 2: [Insert the text of Claim 2 from the patent document]
    • This claim may add a particular feature or condition to the invention described in Claim 1.

Claim Structure and Dependencies

Understanding the dependency between claims is vital. Claims can be categorized into:

  • Method Claims: These describe a process or method.
  • Apparatus Claims: These describe a device or system.
  • Composition Claims: These describe a material or substance.

Technological Context

To fully appreciate the patent, it is necessary to understand the technological field in which it operates.

Prior Art and State of the Art

Prior art refers to existing knowledge and inventions in the field before the filing date of the patent. The state of the art is the current level of development in the field.

  • Relevant Prior Art: Identify key patents and publications that were considered during the examination process.
    • For example, if the patent is in the field of software, prior art might include other software patents and academic papers[4].

Innovations and Contributions

The patent should introduce novel and non-obvious improvements over the prior art.

  • Key Innovations: Highlight the unique aspects of the invention that differentiate it from existing solutions.
    • This could include new algorithms, materials, or system architectures.

Patent Landscape

The patent landscape includes all related patents and applications in the same technological field.

Patent Family

A patent family includes all patents and applications that claim priority from the same initial application.

  • Continuations and Continuations-in-Part: These are subsequent applications that build upon the original application, often with additional claims or improvements[1].

Global Dossier and IP5 Offices

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices.

  • International Filings: Check if the patent has been filed in other countries and the status of those applications.
    • This can be done using the Global Dossier tool or by searching through the patent offices of other countries[4].

Legal and Procedural Aspects

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA)[1].

  • Terminal Disclaimers: These are used to overcome ODP rejections by disclaiming the term of the later patent beyond the expiration date of the earlier patent.
    • For example, if multiple patents in a family have different PTA grants, a terminal disclaimer might be necessary to ensure that the later patents do not extend beyond the earliest expiration date[1].

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

PTA and PTE are mechanisms to adjust the term of a patent due to delays in the prosecution process or regulatory review.

  • PTA: Adjusts the patent term for delays caused by the USPTO during prosecution.
    • This is governed by 35 U.S.C. § 154(b)[1].
  • PTE: Extends the patent term for delays caused by regulatory review, such as FDA approval.
    • This is governed by 35 U.S.C. § 156[1].

Search and Analysis Tools

Several tools are available to aid in the search and analysis of patents:

Patent Public Search

The USPTO's Patent Public Search tool provides enhanced access to prior art and allows for more flexible and powerful searches[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating IP5 Offices, making it easier to visualize search results for the same invention across different offices[4].

Key Takeaways

  • Claims Structure: Understand the independent and dependent claims to grasp the full scope of the invention.
  • Technological Context: Recognize the prior art and state of the art to appreciate the novelty and non-obviousness of the invention.
  • Patent Landscape: Analyze the patent family and international filings to understand the broader patent landscape.
  • Legal Considerations: Be aware of ODP, PTA, and PTE to ensure compliance and maximize patent term.

FAQs

  1. What is the significance of independent claims in a patent?

    • Independent claims define the broadest scope of the invention and stand alone without relying on other claims.
  2. How does Obviousness-Type Double Patenting (ODP) affect patent validity?

    • ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by an earlier patent, ensuring that the later patent does not extend beyond the earliest expiration date.
  3. What is the difference between Patent Term Adjustment (PTA) and Patent Term Extension (PTE)?

    • PTA adjusts the patent term for delays caused by the USPTO during prosecution, while PTE extends the patent term for delays caused by regulatory review.
  4. How can the Global Dossier service be used in patent analysis?

    • The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family across different jurisdictions.
  5. What tools are available for searching and analyzing patents?

    • Tools include the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) among others.

Sources

  1. In re Cellect, LLC - United States Court of Appeals for the Federal Circuit[1].
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Search for patents - USPTO[4].
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States[5].

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,826,335

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-002 May 1, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF CATAPLEXY OR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY WITH A ONCE-NIGHTLY GAMMA-HYDROXYBUTYRATE FORMULATION ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 11,826,335

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 109376 ⤷  Try for Free
Australia 2017300845 ⤷  Try for Free
Australia 2020231916 ⤷  Try for Free
Australia 2023203055 ⤷  Try for Free
Brazil 112019000848 ⤷  Try for Free
Brazil 112021013766 ⤷  Try for Free
Canada 3028878 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.